UCB (portfolio of Over-The-Counter medicine brands) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
UCB (portfolio of Over-The-Counter medicine brands) General Information
Description
A portfolio of Over-The-Counter drug brands in France, Benelux, Switzerland and Greece. The portfolio includes various medicine brands such as Carbolevure, Revitalose, Balsoclase and Toclase as well as different Over-The-Counter assets and patents for the distribution of drugs.
Contact Information
Corporate Office
- Allée de la Recherche, 60
- 1070 Brussels
- Belgium
Corporate Office
- Allée de la Recherche, 60
- 1070 Brussels
- Belgium
UCB (portfolio of Over-The-Counter medicine brands) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
UCB (portfolio of Over-The-Counter medicine brands) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
UCB (portfolio of Over-The-Counter medicine brands) FAQs
-
Where is UCB (portfolio of Over-The-Counter medicine brands) headquartered?
UCB (portfolio of Over-The-Counter medicine brands) is headquartered in Brussels, Belgium.
-
What industry is UCB (portfolio of Over-The-Counter medicine brands) in?
UCB (portfolio of Over-The-Counter medicine brands)’s primary industry is Buildings and Property.
-
Is UCB (portfolio of Over-The-Counter medicine brands) a private or public company?
UCB (portfolio of Over-The-Counter medicine brands) is a Private company.
-
What is the current valuation of UCB (portfolio of Over-The-Counter medicine brands)?
The current valuation of UCB (portfolio of Over-The-Counter medicine brands) is .
-
What is UCB (portfolio of Over-The-Counter medicine brands)’s current revenue?
The current revenue for UCB (portfolio of Over-The-Counter medicine brands) is .
-
Who are UCB (portfolio of Over-The-Counter medicine brands)’s investors?
UCB has invested in UCB (portfolio of Over-The-Counter medicine brands).
-
When was UCB (portfolio of Over-The-Counter medicine brands) acquired?
UCB (portfolio of Over-The-Counter medicine brands) was acquired on 08-Jan-2007.
-
Who acquired UCB (portfolio of Over-The-Counter medicine brands)?
UCB (portfolio of Over-The-Counter medicine brands) was acquired by Laboratoires Pierre Fabre.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process